Filter posts

New Target for Alzheimer’s Disease

Biotechnologists have developed a drug candidate that blocks production of diseasecausing neurotoxins in mouse models Reducing …

Making the Case for Personalized Medicine

Personalized medicine is the customization of healthcare. Already, a suite of molecular approaches is being …

21st Century Cures: Accelerating the Discovery-Development-Delivery Cycle

How can we give patients faster access to innovative treatments and cures? That’s the question …

We Are the Worldview

Now in its 6th consecutive year, Scientific American Worldview: A Global Biotechnology Perspective will have …

NIH, Patients and Industry Ramp Up to AMP-lify Innovation

Speakers at Wednesday’s BIO 2014 Super Session – AMP-lifying Innovation: NIH, Patient Organizations & Leading …

Digital Health in a Mobile World

Healthcare is shaping up to be an important area for all the big technology companies …

Making it Personal

The “valley of death” between drug discovery and the development and provision of therapy is …

My Regeneration

What can today’s generation hope for from regenerative medicine? It’s a frontier for business, the medical profession and society. Regenerative …

Ensuring the Safety and Commercial Success of Biosimilars in the United States

The forthcoming arrival of biosimilars into the U.S has spurred debate over the approaches that …

Fighting Prostate Cancer with Immunotherapy

Advaxis and UC San Francisco join forces to develop and test a range of novel …